The Scottish Medicines Consortium (SMC) does not recommend the use of miconazole muco-adhesive buccal tablets (Loramyc®) within NHS Scotland for the treatment of oropharyngeal candidiasis (OPC) in immunocompromised patients, as the manufacturer did not present a sufficiently robust clinical and economic analysis. 

For more detailed information on the evidence submitted by the manufacturer and considered by the SMC when making their recommendation, please see the drug advice at the link below.